Jarir At Thobari. (2021). Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19. Universitas Gadjah Mada.
Chicago Style (17th ed.) CitationJarir At Thobari. Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19. Universitas Gadjah Mada, 2021.
MLA (9th ed.) CitationJarir At Thobari. Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19. Universitas Gadjah Mada, 2021.
Warning: These citations may not always be 100% accurate.